| 0.1137 0.011 (10.39%) | 08-03 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.19 | 1-year : | 0.24 |
| Resists | First : | 0.16 | Second : | 0.2 |
| Pivot price | 0.11 |
|||
| Supports | First : | 0.09 | Second : | 0.07 |
| MAs | MA(5) : | 0.1 |
MA(20) : | 0.11  |
| MA(100) : | 0.16 |
MA(250) : | 0.92 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 11.1 |
D(3) : | 9.5 |
| RSI | RSI(14): 47.7 |
|||
| 52-week | High : | 5.17 | Low : | 0.09 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ LIMN ] has closed above bottom band by 49.7%. Bollinger Bands are 22.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.11 - 0.11 | 0.11 - 0.11 |
| Low: | 0.1 - 0.1 | 0.1 - 0.1 |
| Close: | 0.1 - 0.1 | 0.1 - 0.1 |
Mon, 27 Jul 2026
Liminatus Pharma Ord Shs Class A (LIMN) Cash Flow - TradingKey
Wed, 22 Jul 2026
Samda Biolab discloses 5.1% Liminatus Pharma (LIMN) ownership position - Stock Titan
Wed, 15 Jul 2026
Form 13D/A Liminatus Pharma For: 14 July By Investing.com - Investing.com Nigeria
Mon, 06 Jul 2026
Form 4 Liminatus Pharma Inc For: 6 July By Investing.com - Investing.com Canada
Fri, 22 May 2026
Liminatus Pharma (LIMN) Stock: Nasdaq Delisting Warning Sparks Volatile Trading Session - Blockonomi
Fri, 22 May 2026
Liminatus Pharma (LIMN) Stock Jumps 31% Despite Looming Nasdaq Delisting Threat - MoneyCheck
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 67 (M) |
| Shares Float | 24 (M) |
| Held by Insiders | 33.7 (%) |
| Held by Institutions | 2.2 (%) |
| Shares Short | 2,400 (K) |
| Shares Short P.Month | 910 (K) |
| EPS | -0.25 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -12 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -0.46 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.65 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|